vs
CSG SYSTEMS INTERNATIONAL INC(CSGS)とP3 Health Partners Inc.(PIII)の財務データ比較。上の社名をクリックして会社を切り替えられます
P3 Health Partners Inc.の直近四半期売上が大きい($384.8M vs $323.1M、CSG SYSTEMS INTERNATIONAL INCの約1.2倍)。CSG SYSTEMS INTERNATIONAL INCの純利益率が高く(2.2% vs -19.6%、差は21.8%)。P3 Health Partners Inc.の前年同期比売上増加率が高い(3.8% vs 2.0%)。過去8四半期でCSG SYSTEMS INTERNATIONAL INCの売上複合成長率が高い(4.6% vs -0.5%)
中国南玻集団股フン有限公司は中国最大級の建築用ガラスメーカーで、浮きガラス、建築用ガラス、ディスプレイ用ガラス、自動車用ガラス、コーティングガラス、鏡、カラーフィルターガラス、太陽光発電用ガラス、省エネガラスなど多種多様なガラス製品の製造・販売を手がけています。
P3 Health Partners Inc.は主に米国で事業を展開する人口健康管理と価値基準型医療サービス企業です。プライマリケア提供者や医療システムと提携し、特にメディケアアドバンテージ加入者を中心に質の高い統合医療を提供し、医療アウトカムの向上と不要な医療費の削減に取り組んでいます。
CSGS vs PIII — 直接比較
損益計算書 — Q4 FY2025 vs Q4 FY2025
| 指標 | ||
|---|---|---|
| 売上 | $323.1M | $384.8M |
| 純利益 | $7.0M | $-75.5M |
| 粗利率 | 50.0% | — |
| 営業利益率 | 9.0% | -40.0% |
| 純利益率 | 2.2% | -19.6% |
| 売上前年比 | 2.0% | 3.8% |
| 純利益前年比 | -79.7% | -28.8% |
| EPS(希薄化後) | $0.24 | $-23.08 |
緑 = その指標でリード。会計年度がずれている場合は期間が異なる場合あり
8四半期 売上・利益トレンド
並べて比較する四半期履歴。決算期がずれていても暦四半期で整列
| Q4 25 | $323.1M | $384.8M | ||
| Q3 25 | $303.6M | $345.3M | ||
| Q2 25 | $297.1M | $355.8M | ||
| Q1 25 | $299.5M | $373.2M | ||
| Q4 24 | $316.7M | $370.7M | ||
| Q3 24 | $295.1M | $362.1M | ||
| Q2 24 | $290.3M | $379.2M | ||
| Q1 24 | $295.1M | $388.5M |
| Q4 25 | $7.0M | $-75.5M | ||
| Q3 25 | $20.5M | $-31.6M | ||
| Q2 25 | $12.3M | $-20.4M | ||
| Q1 25 | $16.1M | $-20.5M | ||
| Q4 24 | $34.5M | $-58.6M | ||
| Q3 24 | $19.1M | $-46.5M | ||
| Q2 24 | $13.8M | $-12.0M | ||
| Q1 24 | $19.5M | $-18.7M |
| Q4 25 | 50.0% | — | ||
| Q3 25 | 48.1% | — | ||
| Q2 25 | 49.5% | — | ||
| Q1 25 | 48.4% | — | ||
| Q4 24 | 51.3% | — | ||
| Q3 24 | 49.4% | — | ||
| Q2 24 | 47.3% | — | ||
| Q1 24 | 46.5% | — |
| Q4 25 | 9.0% | -40.0% | ||
| Q3 25 | 10.0% | -12.8% | ||
| Q2 25 | 10.0% | -9.6% | ||
| Q1 25 | 9.8% | -10.2% | ||
| Q4 24 | 13.4% | -37.4% | ||
| Q3 24 | 10.8% | -29.5% | ||
| Q2 24 | 8.8% | -8.3% | ||
| Q1 24 | 10.8% | -11.3% |
| Q4 25 | 2.2% | -19.6% | ||
| Q3 25 | 6.7% | -9.1% | ||
| Q2 25 | 4.1% | -5.7% | ||
| Q1 25 | 5.4% | -5.5% | ||
| Q4 24 | 10.9% | -15.8% | ||
| Q3 24 | 6.5% | -12.8% | ||
| Q2 24 | 4.8% | -3.2% | ||
| Q1 24 | 6.6% | -4.8% |
| Q4 25 | $0.24 | $-23.08 | ||
| Q3 25 | $0.73 | $-9.67 | ||
| Q2 25 | $0.44 | $-6.23 | ||
| Q1 25 | $0.57 | $-6.28 | ||
| Q4 24 | $1.20 | $-23.13 | ||
| Q3 24 | $0.67 | $-15.70 | ||
| Q2 24 | $0.48 | $-7.37 | ||
| Q1 24 | $0.68 | $-7.86 |
貸借対照表と財務力
直近四半期の流動性・レバレッジ・純資産のスナップショット
| 指標 | ||
|---|---|---|
| 現金・短期投資手元流動性 | $180.0M | $25.0M |
| 総負債低いほど良い | $539.5M | $228.4M |
| 株主資本純資産 | $283.7M | $-155.2M |
| 総資産 | $1.5B | $656.6M |
| 負債/資本比率低いほどレバレッジが低い | 1.90× | — |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $180.0M | $25.0M | ||
| Q3 25 | $158.4M | $37.7M | ||
| Q2 25 | $145.9M | $38.6M | ||
| Q1 25 | $136.0M | $40.1M | ||
| Q4 24 | $161.8M | $38.8M | ||
| Q3 24 | $118.4M | $63.0M | ||
| Q2 24 | $110.4M | $73.1M | ||
| Q1 24 | $120.8M | $27.3M |
| Q4 25 | $539.5M | $228.4M | ||
| Q3 25 | $538.6M | $252.8M | ||
| Q2 25 | $537.8M | $182.0M | ||
| Q1 25 | $537.6M | $171.1M | ||
| Q4 24 | $538.5M | $108.9M | ||
| Q3 24 | $539.5M | $133.2M | ||
| Q2 24 | $540.5M | $133.1M | ||
| Q1 24 | $541.5M | $118.1M |
| Q4 25 | $283.7M | $-155.2M | ||
| Q3 25 | $289.5M | $-18.7M | ||
| Q2 25 | $290.7M | $44.5M | ||
| Q1 25 | $283.1M | $63.3M | ||
| Q4 24 | $282.6M | $75.9M | ||
| Q3 24 | $288.4M | $120.5M | ||
| Q2 24 | $273.3M | $166.8M | ||
| Q1 24 | $269.3M | $146.6M |
| Q4 25 | $1.5B | $656.6M | ||
| Q3 25 | $1.5B | $683.6M | ||
| Q2 25 | $1.4B | $731.6M | ||
| Q1 25 | $1.4B | $783.9M | ||
| Q4 24 | $1.5B | $783.4M | ||
| Q3 24 | $1.4B | $833.3M | ||
| Q2 24 | $1.4B | $892.8M | ||
| Q1 24 | $1.3B | $855.9M |
| Q4 25 | 1.90× | — | ||
| Q3 25 | 1.86× | — | ||
| Q2 25 | 1.85× | 4.09× | ||
| Q1 25 | 1.90× | 2.71× | ||
| Q4 24 | 1.91× | 1.43× | ||
| Q3 24 | 1.87× | 1.11× | ||
| Q2 24 | 1.98× | 0.80× | ||
| Q1 24 | 2.01× | 0.81× |
キャッシュフローと資本効率
再投資後に実際に生み出すキャッシュ。純利益より操作が難しい
| 指標 | ||
|---|---|---|
| 営業キャッシュフロー直近四半期 | $59.2M | $-25.7M |
| フリーキャッシュフロー営業CF - 設備投資 | $55.8M | — |
| FCFマージンFCF / 売上 | 17.3% | — |
| 設備投資強度設備投資 / 売上 | 1.1% | — |
| キャッシュ転換率営業CF / 純利益 | 8.46× | — |
| 直近12ヶ月FCF直近4四半期 | $141.4M | — |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $59.2M | $-25.7M | ||
| Q3 25 | $47.9M | $-15.4M | ||
| Q2 25 | $37.3M | $-16.6M | ||
| Q1 25 | $11.5M | $-33.5M | ||
| Q4 24 | $82.5M | $-57.2M | ||
| Q3 24 | $39.5M | $-22.6M | ||
| Q2 24 | $43.1M | $-10.2M | ||
| Q1 24 | $-29.4M | $-20.0M |
| Q4 25 | $55.8M | — | ||
| Q3 25 | $43.9M | — | ||
| Q2 25 | $34.6M | — | ||
| Q1 25 | $7.1M | — | ||
| Q4 24 | $76.6M | — | ||
| Q3 24 | $32.0M | — | ||
| Q2 24 | $38.8M | — | ||
| Q1 24 | $-34.1M | — |
| Q4 25 | 17.3% | — | ||
| Q3 25 | 14.5% | — | ||
| Q2 25 | 11.6% | — | ||
| Q1 25 | 2.4% | — | ||
| Q4 24 | 24.2% | — | ||
| Q3 24 | 10.8% | — | ||
| Q2 24 | 13.4% | — | ||
| Q1 24 | -11.6% | — |
| Q4 25 | 1.1% | — | ||
| Q3 25 | 1.3% | — | ||
| Q2 25 | 0.9% | — | ||
| Q1 25 | 1.5% | — | ||
| Q4 24 | 1.9% | 0.0% | ||
| Q3 24 | 2.5% | 0.0% | ||
| Q2 24 | 1.5% | 0.0% | ||
| Q1 24 | 1.6% | 0.0% |
| Q4 25 | 8.46× | — | ||
| Q3 25 | 2.34× | — | ||
| Q2 25 | 3.04× | — | ||
| Q1 25 | 0.71× | — | ||
| Q4 24 | 2.39× | — | ||
| Q3 24 | 2.07× | — | ||
| Q2 24 | 3.12× | — | ||
| Q1 24 | -1.51× | — |
財務フロー比較
売上 → 粗利 → 営業利益 → 純利益のサンキー図
セグメント別売上内訳
CSGS
| Software As A Service And Related Solutions | $287.2M | 89% |
| License And Service | $22.6M | 7% |
| Maintenance | $13.3M | 4% |
PIII
| Capitated Revenue | $366.2M | 95% |
| Health Care Patient Service | $18.6M | 5% |
| Health Care Care Coordination Management Fees | $2.7M | 1% |